Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and flunitrazepam

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with flunitrazepam in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bender, AS; Swinyard, EA; White, HS1
Boast, CA; Gerhardt, SC; Jarvis, MF; Murphy, DE; Williams, M1
Loo, PS; Sills, MA; Williams, M1

Other Studies

3 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and flunitrazepam

ArticleYear
Effect of the selective N-methyl-D-aspartate receptor agonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid on [3H]flunitrazepam binding.
    European journal of pharmacology, 1988, Feb-16, Volume: 147, Issue:1

    Topics: Animals; Binding, Competitive; Flunitrazepam; In Vitro Techniques; Piperazines; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Temperature

1988
The novel N-methyl-D-aspartate (NMDA) antagonist CGS 19755 prevents ischemia-induced reductions of adenosine A1, NMDA, and PCP receptors in gerbil brain.
    Synapse (New York, N.Y.), 1988, Volume: 2, Issue:6

    Topics: Adenosine; Animals; Autoradiography; Female; Flunitrazepam; Gerbillinae; Image Processing, Computer-Assisted; Ischemic Attack, Transient; Pipecolic Acids; Piperazines; Piperidines; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Receptors, Phencyclidine

1988
The NMDA antagonists, CPP and CGS 19755, lack affinity for central benzodiazepine receptors.
    European journal of pharmacology, 1988, Oct-11, Volume: 155, Issue:1-2

    Topics: Animals; Anticonvulsants; Aspartic Acid; Binding, Competitive; Brain; Flunitrazepam; In Vitro Techniques; N-Methylaspartate; Pipecolic Acids; Piperazines; Piperidines; Rats; Receptors, GABA-A

1988